FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Turchinsky Ilia
2. Issuer Name and Ticker or Trading Symbol

My Size, Inc. [ MYSZ ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Technology Officer
(Last)          (First)          (Middle)

HAYARDEN 4
3. Date of Earliest Transaction (MM/DD/YYYY)

5/25/2020
(Street)

AIRPORT CITY, L3 7010000
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to purchase Common Stock (right to buy) $11.4 5/25/2020  D     1004   (1)5/29/2024 Common Stock, $.001 par value per share 1004  (2)0 D  
Option to purchase Common Stock (right to buy) $1.04 5/25/2020  A   1004     (1)5/29/2025 Common Stock, $.001 par value per share 1004  (2)1004 D  
Option to purchase Common Stock (right to buy) $13.65 5/25/2020  D     2667   (3)9/6/2023 Common Stock, $.001 par value per share 2667  (4)0 D  
Option to purchase Common Stock (right to buy) $1.04 5/25/2020  A   2667     (3)9/6/2024 Common Stock, $.001 par value per share 2667  (4)2667 D  

Explanation of Responses:
(1) Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
(2) Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.
(3) Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on July 1, 2019, one third of the total shares vests on July 1, 2020 and the remaining one third of the total shares vests on July 1, 2021.
(4) Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the option granted to the reporting person on April 15, 2019 having a lower exercise price of $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of September 6, 2024. All of the other terms of the option remained unchanged.

Remarks:
On November 15, 2019, the Company implemented a 1-for-15 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Turchinsky Ilia
HAYARDEN 4
AIRPORT CITY, L3 7010000


Chief Technology Officer

Signatures
/s/ Ilia Turchinsky6/8/2020
**Signature of Reporting PersonDate

My Size (NASDAQ:MYSZ)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more My Size Charts.
My Size (NASDAQ:MYSZ)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more My Size Charts.